Daniel Lee

1.4k citations
36 papers · 1.1k · 1 hit paper · h-index 14

Impact in

    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment
    • Lung Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment
  • Oncology top 10%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Treatments and Mutations 18
    • Brain Metastases and Treatment 3
    • Renal cell carcinoma treatment 3
    • Cancer Immunotherapy and Biomarkers 4
    • Lung Cancer Research Studies 3

Daniel Lee

36 papers receiving 1.1k citations

Daniel Lee's Hit Papers

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial 2022 · 137 citations
1370+1+2Years since publication4080120

Peers

Daniel Lee
Comparison fields: 5 of 50
  • Pulmonary and Respiratory Medicine 748
  • Oncology 186
  • Cancer Research 46
  • Hematology 41
  • Otorhinolaryngology 16
Replace Sevil E. Bavbek with:
Sevil E. Bavbek Türkiye
Joaquín Montalar Spain
Elizabeth Dudnik Israel
Elide Matano Italy
Lynda M. Pyle United Kingdom
Anuradha Chougule India
Mor Tal Moskovitz Israel
Christopher William Lee Canada
Guilherme Harada Brazil
Hari Anant Deshpande United States
Daniel Lee relative to Sevil E. Bavbek Türkiye Sevil E. Bavbek's profile →
Citations per field
00.5×2×4×5.7×
Sevil E. Bavbek · 1×
Citations per year

Countries citing papers authored by Daniel Lee

Since Specialization
Citations

This map shows the geographic impact of Daniel Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lee more than expected).

Fields of papers citing papers by Daniel Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lee. The network helps show where Daniel Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Lee Line = papers co-authored together Daniel Lee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012278
2
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
Hit paper breakdown →
2022137
3 201591
4 202291
5 201383
6 202071
7 202352
8 201740
9 202039
10 201034
11 201325
12 200916
13 202016
14 202415
15 201913
16 202312
17 201411
18 20217
19 20176
20 20176

About Daniel Lee

Daniel Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Cancer Research and Genetics, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (4 papers), Brain Metastases and Treatment (3 papers), Lung Cancer Research Studies (3 papers), Renal cell carcinoma treatment (3 papers), Hemostasis and retained surgical items (1 paper), Abdominal vascular conditions and treatments (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (748 citations), Oncology (186 citations), Cancer Research (46 citations), Hematology (41 citations) and Otorhinolaryngology (16 citations). Daniel Lee has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Joong Sun Lee, Chong Hyun Suh, Sang Jun Park, H. T. Kim, Hanjong Ahn, Hun-Mo Ryoo, Jun Hyuk Hong, Myung‐Ju Ahn, Cheryn Song and Bumsik Hong. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Clinical Cancer Research and Therapeutic Innovation & Regulatory Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact